Description
Pharmacology and Therapeutics of Airway Disease (2nd Ed.)
Coordinators: Chung Kian Fan, Barnes Peter J.
Language: EnglishSubjects for Pharmacology and Therapeutics of Airway Disease:
Keywords
Fluticasone Furoate; Exercise Induced Asthma; Total Serum IgE Concentration; Urinary LTE4; COPD Exacerbation; ICS Therapy; Postbronchodilator FEV1; COPD Patient; Adenosine A2B Receptor Antagonists; Inhaled Corticosteroids; Airway Smooth Muscle; Airway Smooth Muscle Layer; Asthma Control; Leukotriene Receptor Antagonists; Airway Hyperresponsiveness; Inhaled Corticosteroid Therapy; Asthma Therapy Assessment Questionnaire; Nuclear Hormone Receptors; Acute Severe Asthma; b2AR Agonists; Allergen Specific IgE; P38 MAPK; Asthma Exacerbations; Cough Reflex Sensitivity; IgE Synthesis
Approximative price 244.87 €
Subject to availability at the publisher.
Add to cart the print on demandPublication date: 10-2009
Support: Print on demand
Publication date: 09-2019
· 15.2x22.9 cm · Paperback
Description
/li>Contents
/li>Readership
/li>Biography
/li>
Emphasizing state-of-the-art pharmacological and therapeutic approaches in controlling pathophysiological processes in the airways, Pharmacology and Therapeutics of Airway Disease reviews normal and abnormal physiological, biochemical and molecular aspects of the respiratory tract.Covering the basic mechanisms of inflammatory cell activation and pathophysiology in disease, therapeutic ways of controlling inflammation, reversing or preventing airflow obstruction, and symptomatic treatments of advanced disease.
Written as a concise clinical reference guide covering the current and future airway disease treatments, this text encompasses:
pathophysiology of respiratory tract diseases
the methods of measuring airway and clinical responses
the concepts upon which many treatments are used in COPD and asthma conditions
the way in which these treatments work, and how new treatments can be discovered and tested in various patient groups
state-of-the-art pharmacological and therapeutic approaches in controlling pathophysiological processes in the airways
normal and abnormal physiological, biochemical and molecular aspects of the respiratory tract
basic mechanisms of inflammatory cell activation and pathophysiology in disease
therapeutic ways of controlling inflammation
ways of reversing or preventing airflow obstruction, and symptomatic treatments of advanced disease
Preface/Introduction. Part 1: Principles and practice. Principles of pharmacology and therapeutics. Clinical trials in airways disease. Assessment of responses of the airways to therapeutic agents. Pharmacogenetics and pharmacogenomics of airways disease. Delivery of drugs to the airways and lungs. Part 2: Drugs in respiratory diseases. Corticosteroids in airways disease. Bronchodilator therapy in airways disease. Anti-mediator therapy. Cytokines and anti-cytokines. Anti-allergic approaches in airways disease. New anti-inflammatory approaches to therapy of airways disease. Part 3: Therapeutics and treatment approaches. Airway wall remodelling as a concept for airways disease therapeutics. Exacerbations of airways disease. Pharmacology and therapeutics of COPD. Pharmacology and therapeutics of asthma. Pharmacology and therapeutics of cough.